Alan, a French health tech company, has successfully attracted a whopping $460 million investment from the Netherlands-based Prosus, elevating its valuation to an impressive $6.3 billion. This funding will significantly enhance Alan's growth efforts, promoting global expansion and driving innovation
โก
Key Insights
10 editorial insights.
AiFeed24 Teamยทโฑ 1 min readยทNews
Deep Analysis
Multi-Source Intelligence
Found this useful? Share it!


